Literature DB >> 16306515

The origins of pandemic influenza--lessons from the 1918 virus.

Robert B Belshe1.   

Abstract

Mesh：

Year:  2005        PMID： 16306515     DOI： 10.1056/NEJMp058281

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.

Authors:  Carlos del Rio; Jeannette Guarner
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada.

Authors:  Danuta M Skowronski; Yan Li; S Aleina Tweed; Theresa W S Tam; Martin Petric; Samara T David; Fawziah Marra; Nathalie Bastien; Sandra W Lee; Mel Krajden; Robert C Brunham
Journal:  CMAJ       Date:  2007-01-02       Impact factor: 8.262

5.  Influenza vaccination and the elderly: pandemic preparedness.

Authors:  Mary Jo Kasten; Gregory A Poland
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system.

Authors:  James J McSharry; Qingmei Weng; Ashley Brown; Robert Kulawy; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

7.  Proteolytic activation of the 1918 influenza virus hemagglutinin.

Authors:  Chawaree Chaipan; Darwyn Kobasa; Stephanie Bertram; Ilona Glowacka; Imke Steffen; Theodros Solomon Tsegaye; Makoto Takeda; Thomas H Bugge; Semi Kim; Youngwoo Park; Andrea Marzi; Stefan Pöhlmann
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

8.  Virtual epidemic in a virtual city: simulating the spread of influenza in a US metropolitan area.

Authors:  Bruce Y Lee; Virginia L Bedford; Mark S Roberts; Kathleen M Carley
Journal:  Transl Res       Date:  2008-04-03       Impact factor: 7.012

9.  Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.

Authors:  Zhongying Chen; Weijia Wang; Helen Zhou; Amorsolo L Suguitan; Cindy Shambaugh; Lomi Kim; Jackie Zhao; George Kemble; Hong Jin
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 10.  Pandemic influenza planning in nursing homes: are we prepared?

Authors:  Lona Mody; Sandro Cinti
Journal:  J Am Geriatr Soc       Date:  2007-09       Impact factor: 5.562
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.